Hiroki Kumamoto

718 total citations
54 papers, 551 citations indexed

About

Hiroki Kumamoto is a scholar working on Organic Chemistry, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Hiroki Kumamoto has authored 54 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Organic Chemistry, 25 papers in Infectious Diseases and 22 papers in Molecular Biology. Recurrent topics in Hiroki Kumamoto's work include HIV/AIDS drug development and treatment (25 papers), Carbohydrate Chemistry and Synthesis (14 papers) and Biochemical and Molecular Research (12 papers). Hiroki Kumamoto is often cited by papers focused on HIV/AIDS drug development and treatment (25 papers), Carbohydrate Chemistry and Synthesis (14 papers) and Biochemical and Molecular Research (12 papers). Hiroki Kumamoto collaborates with scholars based in Japan, United States and Belgium. Hiroki Kumamoto's co-authors include Hiromichi Tanaka, Kazuhiro Haraguchi, Masanori Baba, Yung‐Chi Cheng, Keisuke Kato, Tadashi Miyasaka, Hiroyuki Hayakawa, Luigi A. Agrofoglio, Takao Nitanda and Julie Broggi and has published in prestigious journals such as Chemical Communications, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Hiroki Kumamoto

48 papers receiving 538 citations

Peers

Hiroki Kumamoto
Anne M. Exall United Kingdom
Ed W. McLean United States
Woo‐Baeg Choi United States
Henry G. Howell United States
Katherine Z. Borysko United States
V. S. Bhadti United States
Matthew D. Selby United Kingdom
Ugo Pradère France
Paul R. Brodfuehrer United States
Muthian Shanmugasundaram United States
Anne M. Exall United Kingdom
Hiroki Kumamoto
Citations per year, relative to Hiroki Kumamoto Hiroki Kumamoto (= 1×) peers Anne M. Exall

Countries citing papers authored by Hiroki Kumamoto

Since Specialization
Citations

This map shows the geographic impact of Hiroki Kumamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Kumamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Kumamoto more than expected).

Fields of papers citing papers by Hiroki Kumamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroki Kumamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Kumamoto. The network helps show where Hiroki Kumamoto may publish in the future.

Co-authorship network of co-authors of Hiroki Kumamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Kumamoto. A scholar is included among the top collaborators of Hiroki Kumamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Kumamoto. Hiroki Kumamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yasutake, Y., Shin‐ichiro Hattori, Hiroki Kumamoto, et al.. (2024). Deviated binding of anti-HBV nucleoside analog E-CFCP-TP to the reverse transcriptase active site attenuates the effect of drug-resistant mutations. Scientific Reports. 14(1). 15742–15742. 1 indexed citations
2.
Takamatsu, Yuki, Sanae Hayashi, Hiroki Kumamoto, et al.. (2023). A novel anti-HBV agent, E-CFCP, restores Hepatitis B virus (HBV)-induced senescence-associated cellular marker perturbation in human hepatocytes. Virus Research. 329. 199094–199094. 5 indexed citations
3.
Kumamoto, Hiroki, Nobuyo Higashi‐Kuwata, Sanae Hayashi, et al.. (2023). Synthesis of novel entecavir analogues having 4′-cyano-6′′-fluoromethylenecyclopentene skeletons as an aglycone moiety as highly potent and long-acting anti-hepatitis B virus agent. RSC Advances. 13(23). 15999–16011. 2 indexed citations
4.
Higashi‐Kuwata, Nobuyo, Sanae Hayashi, Hiroki Kumamoto, et al.. (2020). Identification of a novel long-acting 4’-modified nucleoside reverse transcriptase inhibitor against HBV. Journal of Hepatology. 74(5). 1075–1086. 21 indexed citations
5.
Kumamoto, Hiroki, Manabu Aoki, Masayuki Amano, et al.. (2019). Synthesis and evaluation of the anti-hepatitis B virus activity of 4′-Azido-thymidine analogs and 4′-Azido-2′-deoxy-5-methylcytidine analogs: structural insights for the development of a novel anti-HBV agent. Nucleosides Nucleotides & Nucleic Acids. 39(4). 518–529. 1 indexed citations
6.
Haraguchi, Kazuhiro, Yutaka Kubota, Hiroki Kumamoto, et al.. (2013). From the Chemistry of Epoxy-Sugar Nucleosides to the Discovery of Anti-HIV Agent 4'-ethynylstavudine-Festinavir. Current Pharmaceutical Design. 19(10). 1880–1897. 8 indexed citations
7.
Kumamoto, Hiroki, Yasuyuki Kitagawa, Hiroshi Abe, et al.. (2012). Tuning efficiency of the 4-exo-trig cyclization by the electronic effect: ring closure of 3,3-difluoro-4-pentenyl carbon radicals and synthesis of a gem-difluorocyclobutane nucleoside. Chemical Communications. 48(89). 10993–10993. 7 indexed citations
8.
Kumamoto, Hiroki, Masaki Kobayashi, & Hideaki Tanaka. (2009). Synthesis of 5'-fluoro-2'- -methylneplanocin analogues. Nucleic Acids Symposium Series. 53(1). 101–102. 1 indexed citations
9.
Kubota, Yutaka, et al.. (2009). Synthesis of 4'-substituted cordycepins via benzenesulfenylation at the 4'-position as a key step. Nucleic Acids Symposium Series. 53(1). 99–100. 1 indexed citations
10.
Kumamoto, Hiroki, Dimitri Topalis, Julie Broggi, et al.. (2008). Preparation of acyclo nucleoside phosphonate analogues based on cross-metathesis. Tetrahedron. 64(16). 3517–3526. 34 indexed citations
11.
Topalis, Dimitri, Hiroki Kumamoto, Laurence Dugué, et al.. (2007). Looking for New Pyrimidine Acyclic Nucleotide Analogues Designed for Phosphorylation by Human Ump-Cmp Kinase. Nucleosides Nucleotides & Nucleic Acids. 26(10-12). 1369–1373.
12.
Topalis, Dimitri, Hiroki Kumamoto, Laurence Dugué, et al.. (2007). Nucleotide binding to human UMP‐CMP kinase using fluorescent derivatives − a screening based on affinity for the UMP‐CMP binding site. FEBS Journal. 274(14). 3704–3714. 12 indexed citations
13.
Kumamoto, Hiroki, et al.. (2007). Synthesis Of Novel 4′-Modified Neplanocin A Analogues And Their Inhibitory Activity AgainstS-Adenosyl-L-l-Homocysteine Hydrolase. Nucleosides Nucleotides & Nucleic Acids. 26(6-7). 733–736. 2 indexed citations
14.
Roy, Vincent, Hiroki Kumamoto, Sabine Berteina‐Raboin, et al.. (2007). Cross-Metathesis Mediated Synthesis of New Acyclic Nucleoside Phosphonates. Nucleosides Nucleotides & Nucleic Acids. 26(10-12). 1399–1402. 2 indexed citations
15.
Kumamoto, Hiroki, Kazuhiro Haraguchi, Hiromichi Tanaka, et al.. (2005). Synthesis of (±)-4′-Ethynyl and 4′-Cyano Carbocyclic Analogues of Stavudine (d4T). Nucleosides Nucleotides & Nucleic Acids. 24(2). 73–83. 14 indexed citations
16.
Kumamoto, Hiroki, et al.. (2003). Stannylation Approach to the Synthesis of 2′- and 3′-Substituted Analogues of 2′,3′-Didehydro-2′,3′-dideoxynucleosides. Nucleosides Nucleotides & Nucleic Acids. 22(5-8). 767–769.
17.
18.
Toyohara, Jun, Akio Hayashi, Hiromichi Tanaka, et al.. (2003). Development of radioiodinated nucleoside analogs for imaging tissue proliferation: comparisons of six 5-iodonucleosides. Nuclear Medicine and Biology. 30(7). 687–696. 19 indexed citations
19.
20.
Kumamoto, Hiroki & Hiromichi Tanaka. (2002). New Aspects in the Lithiation Chemistry of Nucleosides: Anionic Migration of Silyl and Stannyl Groups.. Journal of Synthetic Organic Chemistry Japan. 60(2). 145–154. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne M. Exall Breakdown of academic impact, for papers by Ed W. McLean Breakdown of academic impact, for papers by Woo‐Baeg Choi Breakdown of academic impact, for papers by Henry G. Howell Breakdown of academic impact, for papers by Katherine Z. Borysko Breakdown of academic impact, for papers by V. S. Bhadti Breakdown of academic impact, for papers by Matthew D. Selby Breakdown of academic impact, for papers by Ugo Pradère Breakdown of academic impact, for papers by Paul R. Brodfuehrer Breakdown of academic impact, for papers by Muthian Shanmugasundaram
Rankless by CCL
2026